Admission Date:  [**2118-7-12**]     Discharge Date:  [**2118-7-15**]  Date of Birth:   [**2058-8-29**]     Sex:  M  Service:  [**Location (un) **]  HISTORY OF PRESENT ILLNESS:  The patient is a 59-year-old male with metastatic pancreatic cancer who is status post Whipple procedure in [**2116-9-30**], status post chemotherapy with cisplatin, gemcitabine, Xeloda, Taxol, who presented to the [**Hospital1 **] [**First Name (Titles) 151**] [**Last Name (Titles) 16169**] gastrointestinal bleeding.
On [**2118-7-12**], the patient presented to the [**Hospital1 **] with complaints of coffee-grounds emesis, and bright red blood per rectum, as well as clots in his stools.
The patient was given packed red blood cells and intravenous fluids and stabilized to a hematocrit of 30.
Pancreatic cancer diagnosed in [**2115**]; status post choledochojejunostomy, gastrojejunostomy, percutaneous endoscopic jejunostomy.
Zoloft 100 mg p.o.
Insulin NPH 7 units q.a.m.
The abdominal examination revealed a right upper quadrant incisional scar as well as a percutaneous endoscopic jejunostomy tube scar in the left upper quadrant.
A peripherally inserted central catheter line was placed as per the instructions of his oncologist, Dr. [**First Name8 (NamePattern2) **] [**Last Name (NamePattern1) **].
DISCHARGE DISPOSITION:  He was discharged to home on [**7-15**] with instructions to follow up with his oncologist (Dr. [**First Name (STitle) **] on [**2118-7-18**] for his next cycle of Taxotere chemotherapy.
MEDICATIONS ON DISCHARGE:  (He was discharged on his original medications which included) 1.
Zoloft 100 mg p.o.
Insulin NPH 7 units q.a.m.
